Pasireotide
Wikipedia on Answers.com:
Top
Pasireotide
 |
|
|---|---|
| Systematic (IUPAC) name | |
| [(3S,6S,9S,12R,15S,18S,20R)-9-(4-aminobutyl)-3-benzyl-12-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-phenyl-6-[(4-phenylmethoxyphenyl)methyl]-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-20-yl] N-(2-aminoethyl)carbamate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Investigational |
| Identifiers | |
| CAS number | 396091-73-9  |
| ATC code | H01CB05 |
| PubChem | CID 9941444 |
| UNII | 98H1T17066 |
| Synonyms | SOM230 |
| Chemical data | |
| Formula | C58H66N10O9 |
| Mol. mass | 1107.26 g/mol |
 (what is this?) (verify) |
|
Pasireotide (SOM230) is an orphan drug approved in Europe for the treatment of Cushing's disease.[1] [2] It was developed by Novartis. Pasireotide is a somatostatin analog which has a 40-fold increased affinity to somatostatin receptor 5 than other somatostatin analogs.
The drug showed therapeutical potential in a recent study (PASPORT-CUSHINGS B2305) where 162 patients were treated with either 2x 600 µg or 2x 900 µg pasireotide s.c. daily.[3] The effectiveness of the treatment was checked by the UFC-value (urinary free cortisol) after six months of treatment. The mean reduction of UFC after six months was 47.9%, which also lead to amelioration of clinical symptoms such as blood pressure, cholesterol value, and weight loss.
References
- ^ "Error: no
|title=specified when using {{Cite web}}". http://finance.yahoo.com/news/novartis-drug-signifor-approved-eu-051703038.html;_ylt=A2KJ3CQ_5qBPSVwAuzLQtDMD. - ^ Mancini et al. Therapeutics and Clinical Risk Management 2010;6:505-516
- ^ Colao et al. Pasireotide (SOM230) provides clinical benefit in patients with Cushing’s disease: results from a large, 12-month, randomized-dose, double-blind, Phase III study, Abstract OC1.7. European Neuroendocrine Association (ENEA) 14th Congress, 2010:62-63
|
||||||||||||||||||||||||||||||||||
 |
This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
Post a question - any question - to the WikiAnswers community:
Copyrights:
Wikipedia on Answers.com
This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article Pasireotide.
Read more